The serum levels of Ceruloplasmin (CER), Properdin Factor B (PFB) and Copper (CU) were evaluated in a series of 40 patients with Hodgkin's Disease and 46 patients with non-Hodgkin's lymphoma. Concentrations of CER and PFB were determined by rate nephelometry and CU concentrations by the bathocuproine colorimetric method. The results obtained demonstrated that CER, together with the well documented CU, can be used for monitoring Hodgkin's Disease.
LaheyM.E., GublerC.J., CartwrghtG.E., WintrobeM.M.. Studies on copper metabolism - VI. Blood copper in normal human subjects.J Clin Invest1953; 32: 322–8.
2.
BromanL.. The function of ceruloplasmin? A moot question. In: Waless O, ed. Molecular basis of some aspects of mental activity.New York: Academic Press,1967; 2: 131–46.
3.
FriedenE., OsakiJ.. Ferroxidase and ferrireductases, their role in iron metabolism.Adv Exp Med Biol1974; 48: 235–65.
4.
ThorlingE.B., JensenK.B., AndersenC.J., JensenY.. Cobre serico y ceruloplasmina en la enfermedad de Hodgkin.Folia Clin Int (Barcelona)1965; 15(1): 2–12.
5.
LinderM.L., MoorJ.R., WrightK.. Ceruloplasmin analysis in diagnosis and treatment of human lung, breast and gastrointestinal cancers.J Natl Cancer Inst1981; 67: 263–75.
6.
ScudderP.R., AL-TiminiD., McMurrayW., WhiteA.G., ZoobB.C., DormandyT.L.. Serum copper and related variables in rheumatoid arthritis.Ann Rheum Dis1978; 37: 67–70.
7.
GublerC.J., LaheyM.E., CartwrightG.E., WintrobeM.M.. Studies on copper metabolism-IX. The transportation of copper in blood.J Clin Invest1953; 32: 405–14.
8.
WintrobeM.M., CartwrightG.E., GublerC.J.. Studies on the function and metabolism of copper.J Nutr1953; 50: 395–419.
9.
MarkowitzH., GublerC.J., MahoneyJ.P., CartwrightG.E., WintrobeM.M.. Studies on copper metabolism-XIV. Copper, ceruloplasmin, and oxidase activity in sera of normal human subjects, pregnant women and patients with infection, hepato-lenticular degeneration and nephrotic syndrome.J Clin Invest1955; 34: 1498–508.
10.
LaheyM.E., GublerC.J., CartwrightG.E., WintrobeM.M.. Studies on copper metabolism-VII. Blood copper in pregnancy and various pathologic states.J Clin Invest1953; 32: 329–39.
11.
RussE., RaymunJ.. Influence of estrogens on total serum copper and ceruloplasmin.Proc Exp Biol Med1956; 92: 465–6.
12.
KrebsN.F., HambidgeK.M., JacobsM.A.. Plasma copper and ceruloplasmin concentrations during lactation.Fed Proc (Abstr)1984; 43: 1855.
13.
ChakrabortyP.K., GhoshA., ChowdhuryJ.R.. Ceruloplasmin in human malignancies.Acta Med Okayama.1984; 38: 315–20.
PagliardiE., CravarioA., BrusaL., CantinoD., GiangrandiE.. Indagine sul metabolismo del rame nel morbo di Hodgkin.Haematologica1963; 48: 209–28.
16.
PagliardiE., GiangrandiE.. Clinical significance of the blood copper in Hodgkin's disease.Acta Haemat1960; 24: 201–12.
17.
HrgovcicM., TessmerC.F., MincklerT.M., NosierB., TaylorG.A.. Serum copper levels in lymphoma and leukemia: special reference to Hodgkin's disease.Cancer1968; 21: 743–55.
18.
LarsenB., HeronI., ThorlingE.B.. Elevated serum Cu in Hodgkin's disease and inhibitory effect of ceruloplasma on lymphocyte response in vitro.Eur J Cancer1980; 16: 415–21.
19.
Muller-EberhardH.J., SchreiberR.D.. Molecular biology and chemistry of the alternative pathway of complement.Adv Immunol1980; 29: 1–47.
20.
WallensteinS., ZuckerC.L., FleissJ.L.. Some statistical methods useful in circulation research.Circul Res1980; 47: 1–9.
21.
ThorlingE.B., ThorlingK.. The clinical usefulness of serum copper determinations in Hodgkin's disesase.Cancer1976; 38: 225–31.
22.
HrgovicicM., TessmerC.F., ThomasF.B., FullerL.M., GambleJ.F., ShullenbergerC.C.. Significance of serum copper levels in adult patients with Hodgkin's disease.Cancer1973; 31: 1337–45.
